Travere Therapeutics Inc (TVTX) Insider Trading
Total insider buys:
- $0.00
Total insider sells:
- $7,764,741.05
Most recent insider trade:
- Sept. 30, 2024
Most active insider trader:
- Eric M Dube
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Sept. 30, 2024 | Director | 40,000 | $14.06 | Sell | $562,400.00 | |
Sept. 9, 2024 | CFO | 2,490 | $11.52 | Sell | $28,684.80 | |
Sept. 9, 2024 | CEO | 21,125 | $11.52 | Sell | $243,360.00 | |
Sept. 9, 2024 | Insider | 2,191 | $11.52 | Sell | $25,240.32 | |
Sept. 9, 2024 | SVP | 4,387 | $11.52 | Sell | $50,538.24 | |
Sept. 4, 2024 | CFO | 514 | $9.51 | Sell | $4,888.14 | |
April 11, 2024 | CFO | 54 | $6.74 | Sell | $363.96 | |
Feb. 1, 2024 | Insider | 4,195 | $8.53 | Sell | $35,783.35 | |
Feb. 1, 2024 | CEO | 19,122 | $8.70 | Sell | $166,361.40 | |
Feb. 1, 2024 | SVP | 4,764 | $8.71 | Sell | $41,494.44 | |
Feb. 1, 2024 | CFO | 3,818 | $8.53 | Sell | $32,567.54 | |
Feb. 1, 2024 | CAO | 2,820 | $8.53 | Sell | $24,054.60 | |
Jan. 23, 2024 | CAO | 910 | $9.07 | Sell | $8,253.70 | |
Jan. 23, 2024 | CFO | 853 | $9.07 | Sell | $7,736.71 | |
Jan. 23, 2024 | SVP | 2,062 | $8.96 | Sell | $18,475.52 | |
Jan. 23, 2024 | CEO | 7,873 | $8.96 | Sell | $70,542.08 | |
Jan. 23, 2024 | Insider | 1,559 | $9.07 | Sell | $14,140.13 | |
Jan. 3, 2024 | Insider | 2,069 | $9.48 | Sell | $19,614.12 | |
Oct. 3, 2023 | Insider | 3,091 | $8.25 | Sell | $25,500.75 | |
Sept. 5, 2023 | SVP | 1,815 | $14.71 | Sell | $26,698.65 | |
Sept. 5, 2023 | CFO | 457 | $14.71 | Sell | $6,722.47 | |
Sept. 5, 2023 | CEO | 4,455 | $14.71 | Sell | $65,533.05 | |
May 10, 2023 | CFO | 455 | $16.59 | Sell | $7,548.45 | |
May 10, 2023 | SVP | 825 | $16.59 | Sell | $13,686.75 | |
May 10, 2023 | CAO | 436 | $16.59 | Sell | $7,233.24 | |
April 11, 2023 | CFO | 47 | $21.49 | Sell | $1,010.03 | |
Feb. 1, 2023 | CAO | 1,671 | $21.75 | Sell | $36,344.25 | |
Feb. 1, 2023 | Insider | 1,779 | $21.75 | Sell | $38,693.25 | |
Feb. 1, 2023 | CEO | 8,196 | $22.25 | Sell | $182,361.00 | |
Feb. 1, 2023 | SVP | 2,590 | $22.25 | Sell | $57,627.50 | |
Feb. 1, 2023 | CFO | 1,588 | $21.75 | Sell | $34,539.00 | |
Jan. 24, 2023 | SVP | 2,062 | $21.50 | Sell | $44,333.00 | |
Jan. 24, 2023 | CEO | 6,442 | $21.50 | Sell | $138,503.00 | |
Jan. 24, 2023 | Insider | 1,550 | $21.90 | Sell | $33,945.00 | |
Jan. 24, 2023 | CAO | 905 | $21.90 | Sell | $19,819.50 | |
Jan. 24, 2023 | CFO | 852 | $21.90 | Sell | $18,658.80 | |
Jan. 5, 2023 | CEO | 5,625 | $20.75 | Sell | $116,718.75 | |
Jan. 4, 2023 | Insider | 2,051 | $20.75 | Sell | $42,558.25 | |
Oct. 4, 2022 | Insider | 3,042 | $25.68 | Sell | $78,118.56 | |
Sept. 13, 2022 | CAO | 349 | $28.00 | Sell | $9,772.00 | |
May 11, 2022 | Director | 2,575 | $21.92 | Sell | $56,444.00 | |
May 11, 2022 | SVP | 1,563 | $21.71 | Sell | $33,932.73 | |
May 10, 2022 | CAO | 436 | $21.51 | Sell | $9,378.36 | |
May 10, 2022 | CFO | 825 | $21.51 | Sell | $17,745.75 | |
Jan. 31, 2022 | Insider | 1,125 | $27.40 | Sell | $30,825.00 | |
Jan. 31, 2022 | CEO | 4,813 | $27.40 | Sell | $131,876.20 | |
Jan. 31, 2022 | CFO | 1,238 | $27.40 | Sell | $33,921.20 | |
Jan. 31, 2022 | SVP | 1,350 | $27.40 | Sell | $36,990.00 | |
Jan. 31, 2022 | CAO | 798 | $26.51 | Sell | $21,154.98 | |
Jan. 24, 2022 | CEO | 7,873 | $24.98 | Sell | $196,667.54 |
Insiders are selling Travere Therapeutics Inc stock.
The insider traders at Travere Therapeutics Inc are: Eric M Dube, Christopher R Cline, Sandra Calvin, Peter Heerma, William E Rote, Elizabeth E Reed, Steve Aselage, Laura Clague, Jula Inrig, Jeffrey A Meckler, Noah L. Rosenberg, and Noah L Rosenberg
The most active insider trader at Travere Therapeutics Inc is Eric M Dube with 13 trades.
Steve Aselage has sold the most Travere Therapeutics Inc stock with a total value of $3,633,518.88.
The most recent insider trade for Travere Therapeutics Inc was on Sept. 30, 2024.
The single biggest insider sell for Travere Therapeutics Inc was from Steve Aselage with a total value of $1,575,000.00 on Oct. 7, 2021.